COMBINED FARNESOID X RECEPTOR AGONIST AND SOLUBLE EPOXIDE HYDROLASE INHIBITOR TREATS PROGRESSIVE RENAL FIBROSIS

MLA

Olexiy Savchuk, et al. “Combined Farnesoid X Receptor Agonist and Soluble Epoxide Hydrolase Inhibitor Treats Progressive Renal Fibrosis.” The FASEB Journal, vol. 34, Apr. 2020, p. 1. EBSCOhost, https://doi.org/10.1096/fasebj.2020.34.s1.03729.

APA

Olexiy Savchuk, Anna Stavniichuk, Wojciech K. Jankiewicz, Abdul H. Khan, Benjamin J. Nolan, John D. Imig, Amy N. Vogel, & Daniel Merk. (2020). Combined Farnesoid X Receptor Agonist and Soluble Epoxide Hydrolase Inhibitor Treats Progressive Renal Fibrosis. The FASEB Journal, 34, 1. https://doi.org/10.1096/fasebj.2020.34.s1.03729

Chicago

Olexiy Savchuk, Anna Stavniichuk, Wojciech K. Jankiewicz, Abdul H. Khan, Benjamin J. Nolan, John D. Imig, Amy N. Vogel, and Daniel Merk. 2020. “Combined Farnesoid X Receptor Agonist and Soluble Epoxide Hydrolase Inhibitor Treats Progressive Renal Fibrosis.” The FASEB Journal 34 (April): 1. doi:10.1096/fasebj.2020.34.s1.03729.